Extended-release lamotrigine in the treatment of patients with epilepsy

By Syed Tanvir U   Sajatovic Martha  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1579-1585

Informa Healthcare

Access to resources Recommend Favorite

Photostability of extended-release matrix formulations

By Maggi L.   Ochoa Machiste E.   Fasani E.   Albini A.   Segale L.   Conte U.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 1, 2003-01 ,pp. : 99-105

Elsevier

Access to resources Recommend Favorite

Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

By Gayatri Sathyan  

Clinical Pharmacokinetics, Vol. 43, Iss. 14, 2004-01 ,pp. : 1059-1068

Adis International

Access to resources Recommend Favorite

Bioavailability of Immediate- and Extended-Release Formulations of Glipizide in Healthy Male Volunteers

By Dhawan Sanju  

Clinical Pharmacokinetics, Vol. 45, Iss. 3, 2006-01 ,pp. : 317-324

Adis International

Access to resources Recommend Favorite

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate

By Maldonado Rafael  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1001-1014

Informa Healthcare

Access to resources Recommend Favorite